Amedeo's Top 20

Amedeo Smart

Independent Medical Education

23 March 2015

Multidisciplinary Journal Club

  1. Linderman SL, Chambers BS, Zost SJ, Parkhouse K, et al.
    Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.
    Proc Natl Acad Sci U S A 2014.

  1. Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, et al.
    Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embol
    Lancet 2015.

  2. Bonati LH, Dobson J, Featherstone RL, Ederle J, et al.
    Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial.
    Lancet 2015;385:529-38.

  3. Nagaoka M, Hatta Y, Kawaoka Y, Malherbe LP, et al.
    Antigen Signal Strength during Priming Determines Effector CD4 T Cell Function and Antigen Sensitivity during Influenza Virus Challenge.
    J Immunol 2014.

  4. Clemens EB, Doherty PC, La Gruta NL, Turner SJ, et al.
    Fixed Expression of Single Influenza Virus-Specific TCR Chains Demonstrates the Capacity for TCR alpha- and beta-Chain Diversity in the Face of Peptide-MHC Class I Specificity.
    J Immunol 2014.

  1. Roberts KL, Manicassamy B, Lamb RA.
    Influenza A virus uses intercellular connections to spread to neighboring cells.
    J Virol 2014.

  2. Levin Y, Kochba E, Kenney R.
    Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: Are all delivery methods the same?
    Vaccine 2014.

  3. Qin T, Yin Y, Wang X, Liu H, et al.
    Whole inactivated avian Influenza H9N2 viruses induce nasal submucosal dendritic cells to sample luminal viruses via transepithelial dendrites and trigger subsequent DC maturation.
    Vaccine 2015.

  4. Mega JL, Stitziel NO, Smith JG, Chasman DI, et al.
    Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
    Lancet 2015.

  5. Sauter CS, Matasar MJ, Meikle J, Schoder H, et al.
    Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.
    Blood 2015.

  1. Molyneux AJ, Birks J, Clarke A, Sneade M, et al.
    The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT).
    Lancet 2015;385:691-7.

  2. Ashour J, Schmidt F, Hanke L, Cragnolini J, et al.
    Intracellular expression of camelid single domain antibodies specific for influenza virus nucleoprotein (NP) uncovers distinct features of its nuclear localization.
    J Virol 2014.

  3. Ren Z, Ji X, Meng L, Wei Y, et al.
    H5N1 Influenza Virus-Like Particle Vaccine Protects Mice from Heterologous Virus Challenge better than Whole Inactivated Virus.
    Virus Res 2015.

  4. Kastelein JJ, Besseling J, Shah S, Bergeron J, et al.
    Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
    Lancet 2015.

  5. Conte G, Sieira J, Ciconte G, de Asmundis C, et al.
    Implantable cardioverter-defibrillator therapy in brugada syndrome: a 20-year single-center experience.
    J Am Coll Cardiol 2015;65:879-88.

  1. Bressler B, Marshall JK, Bernstein CN, Bitton A, et al.
    Clinical Practice Guidelines for the Medical Management of Non-Hospitalized Ulcerative Colitis: The Toronto Consensus.
    Gastroenterology 2015.

  2. Lim KC, Wang VW, Siddiqui FJ, Shi LM, et al.
    Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria.
    Hepatology 2014.

  3. Graham DJ, Reichman ME, Wernecke M, Zhang R, et al.
    Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated with Dabigatran or Warfarin for Non-Valvular Atrial Fibrillation.
    Circulation 2014.

  4. Robak T, Smolewski P.
    Novel target to kill CLL.
    Blood 2015;125:211-2.

  5. Lambiase PD, Barr C, Theuns DA, Knops R, et al.
    Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.
    Eur Heart J 2014;35:1657-65.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016